Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · IEX Real-Time Price · USD
0.650
+0.020 (3.19%)
At close: Apr 24, 2024, 4:00 PM
0.668
+0.018 (2.72%)
After-hours: Apr 24, 2024, 4:53 PM EDT
Clover Health Investments Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for CLOV stock has a target of 1.50, which predicts an increase of 130.77% from the current stock price of 0.65.
Analyst Consensus: Hold
* Price targets were last updated on Aug 11, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for CLOV is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 | 1 |
Sell | 1 | 1 | 1 | 1 | 1 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Citigroup | Citigroup | Hold Maintains $1 → $1.5 | Hold | Maintains | $1 → $1.5 | +130.77% | Aug 11, 2023 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $4 → $3 | Strong Buy | Maintains | $4 → $3 | +361.54% | Mar 6, 2023 |
Credit Suisse | Credit Suisse | Sell Maintains $2.5 → $1.25 | Sell | Maintains | $2.5 → $1.25 | +92.31% | Mar 6, 2023 |
Citigroup | Citigroup | Hold Maintains $3.5 → $1.8 | Hold | Maintains | $3.5 → $1.8 | +176.92% | Nov 16, 2022 |
SVB Leerink | SVB Leerink | Hold Maintains $3 → $1.5 | Hold | Maintains | $3 → $1.5 | +130.77% | Nov 8, 2022 |
Financial Forecast
Revenue This Year
1.30B
from 2.03B
Decreased by -36.03%
Revenue Next Year
1.36B
from 1.30B
Increased by 4.77%
EPS This Year
-0.23
from -0.44
EPS Next Year
-0.20
from -0.23
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | 1.4B | 1.4B | 1.5B | 1.8B |
Avg | 1.3B | 1.4B | 1.4B | 1.7B |
Low | 1.2B | 1.3B | 1.3B | 1.7B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | -32.7% | 10.1% | 13.2% | 24.9% |
Avg | -36.0% | 4.8% | 5.1% | 21.3% |
Low | -40.0% | -3.2% | -3.7% | 16.6% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -0.20 | -0.17 | -0.14 |
Avg | -0.23 | -0.20 | -0.16 |
Low | -0.26 | -0.25 | -0.18 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.